Close Menu

Cell Biosciences

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Paired Ends: May 31, 2011

Premium

Sam Mohan

The protein analysis firm also said that it raised $13 million in connection with the deal.

New Products: Jan 28, 2011

Premium

Cell Biosciences

Paired Ends: Dec 7, 2010

Premium

Mark Dronsfield, Bernd Brust, Jeremy Berg, Mark Poznansky

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Paired Ends: Nov 2, 2010

Premium

Lloyd Kunimoto, Martin Burow, Richard Lussier, Ingrid Choupin

With the assay, the Stanford researchers have begun examining protein phosphorylation levels in a variety of cancer types. The team has also entered into collaborations with several pharmaceutical firms to investigate the effects of therapeutic agents on protein phosphorylation levels in tumor cells.

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the company said.

New Products: Apr 16, 2010

Premium

Cell Biosciences, Proteome Software, TTP LabTech

Pages

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.